Levothroid and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Levothroid (levothyroxine sodium), especially for people who are female, 50-59 old, also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Levothroid. It is created by eHealthMe based on reports of 8,088 people who have side effects when taking Levothroid from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,973 Levothroid users. Check the latest studies of Levothroid.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,541 drugs and 1,876 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Oct, 14, 2025

8,088 people reported to have side effects when taking Levothroid.
Among them, 44 people (0.54%) have Visual acuity reduced.

Could Levothroid cause Visual acuity reduced?

Among these 44 people:

What is the gender of people who have Visual acuity reduced when taking Levothroid? *

female: 68.29 %
male: 31.71 %

What is the age of people who have Visual acuity reduced when taking Levothroid? *

What are other drugs people take besides Levothroid? *

What are other side effects people have besides Visual acuity reduced? *

Nausea (feeling of having an urge to vomit): 12 people, 27.27%
Urinary Tract Infection: 12 people, 27.27%
Pain: 12 people, 27.27%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 25.00%
Fatigue (feeling of tiredness): 11 people, 25.00%
Eye Pain: 10 people, 22.73%
Depression: 10 people, 22.73%
High Blood Pressure: 10 people, 22.73%
Fainting (loss of consciousness and postural tone): 9 people, 20.45%
Dyspnea (difficult or laboured breathing): 9 people, 20.45%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 18.18%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 15.91%
Type 2 Diabetes: 5 people, 11.36%
Urinary Tract Infection: 4 people, 9.09%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 6.82%
Diabetes: 3 people, 6.82%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 4.55%
Skin Wrinkling (wrinkle on skin): 2 people, 4.55%
High Blood Pressure: 2 people, 4.55%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levothroid:

Levothroid (8,973 reports)

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,541 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,876 conditions)

Drugs similar to Levothroid and Visual acuity reduced :

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothroid) and Levothroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.